We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Sues FDA to Claim First-Filer Status on Provigil ANDA from Teva
Mylan Sues FDA to Claim First-Filer Status on Provigil ANDA from Teva
April 10, 2012
In the latest patent commotion over Provigil, Mylan Pharmaceuticals is suing the FDA over its recent decision to grant Teva sole first-filer status for a generic of the sleep disorder drug, saying the FDA overlooked an anti-competitive legal loophole.